Results 231 to 240 of about 42,260 (251)

Resveratrol as a Potential Platelet Inhibitor in Aspirin-Resistant Diabetic Patients-A Novel Therapeutic Strategy Targeting F₀F₁-ATP Synthase Inhibition. [PDF]

Life (Basel)
Panfoli I, Carlini L.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy

Nature Reviews Clinical Oncology, 2023
Amit G Singal
exaly  

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Lancet, The, 2022
Naseer Ahmed, Mohammad Ali, Syed Ali
exaly  

Molecular cancer prevention: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2015
Kenneth Y Tsai, Powel H Brown, Eva Szabo
exaly  

The role of aspirin in cancer prevention

Nature Reviews Clinical Oncology, 2012
Carlo Patrono
exaly  

Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention

Nature Reviews Cardiology, 2018
Davide Capodanno, Roxana Mehran, Marco Valgimigli   +2 more
exaly  

Role of aspirin in primary prevention of cardiovascular disease

Nature Reviews Cardiology, 2019
Carlo Patrono, Colin Baigent
exaly  

Beyond aspirin—cancer prevention with statins, metformin and bisphosphonates

Nature Reviews Clinical Oncology, 2013
Naomi Gronich, Gadi Rennert
exaly  

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

Lancet, The, 2013
Johannes C Kelder
exaly  

Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor

Nature Medicine, 2002
Mauro Perretti, Stefano Marullo, Egle Solito   +2 more
exaly